| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | CA2400570C Heterologous expression of neisserial proteins |
| 04/27/2010 | CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins |
| 04/27/2010 | CA2222129C A method for producing influenza hemagglutinin multivalent vaccines |
| 04/27/2010 | CA2195653C Cells bearing cd4 decoy receptors and related molecules and methods |
| 04/22/2010 | WO2010045261A1 Single chain fc type iii interferons and methods of using same |
| 04/22/2010 | WO2010044894A1 Methods and compositions for treatment of myotonic dystrophy |
| 04/22/2010 | WO2010043232A1 Potato virus a coat protein-based vaccine for treating melanoma and its use |
| 04/22/2010 | WO2010043153A1 Fusion protein inhibiting osteoclast formation, preparation method and drug compositions thereof |
| 04/22/2010 | WO2010043047A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | WO2009029601A3 Receptor-targeting reagents |
| 04/22/2010 | WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof |
| 04/22/2010 | US20100099850 Human cytokine receptor |
| 04/22/2010 | US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis |
| 04/22/2010 | US20100098718 Nucleic acid vectors for immunization |
| 04/22/2010 | US20100098704 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | CA2777486A1 Methods and compositions for treatment of myotonic dystrophy |
| 04/22/2010 | CA2740316A1 Conjugates of glp-1 agonists and uses thereof |
| 04/21/2010 | EP2177616A1 Soluble zcytor 11 cytokine receptors |
| 04/21/2010 | EP2177611A1 Method for measurement of concentration of antigen |
| 04/21/2010 | EP2177534A2 Heteroclitic analogs of class i epitopes |
| 04/21/2010 | EP2177531A2 Cell permeable peptide |
| 04/21/2010 | EP1354204B2 Hcv antigen/antibody combination assay |
| 04/21/2010 | CN101696240A Long lasting growth hormone releasing factor derivatives |
| 04/20/2010 | US7700720 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 04/20/2010 | US7700715 Kit for use in the diagnosis and treatment of cancer |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 04/20/2010 | US7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 04/20/2010 | US7700104 Attenuated Salmonella SP12 mutants as antigen carriers |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | CA2212702C Mucosal vascular addressins and uses thereof |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/15/2010 | WO2010042828A2 Methods and compositions relating to e3 ring-e2 fusion proteins |
| 04/15/2010 | WO2010042751A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042749A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042743A2 Chimeric multiplexes, compositions, and methods for using same |
| 04/15/2010 | WO2010042742A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010041617A1 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2 |
| 04/15/2010 | WO2010040508A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/15/2010 | WO2010040175A1 Amyloid-beta peptide crystal structure |
| 04/15/2010 | US20100093563 Methods and vectors for display of molecules and displayed molecules and collections |
| 04/15/2010 | US20100092500 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 04/15/2010 | CA2739122A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/14/2010 | EP2174952A2 glp-1 (glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance |
| 04/14/2010 | EP2173890A1 Biological active proteins having increased in vivo and/or vitro stability |
| 04/14/2010 | EP2173773A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 04/14/2010 | EP1440085B1 Transient immortalization of cells by oncogenic proteins or telomerase |
| 04/14/2010 | CN101693742A anti-igf-i receptor antibody |
| 04/13/2010 | US7696321 Molecules and methods for inhibiting shedding of KIM-1 |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7695962 Polypeptides and nucleic acids encoding same |
| 04/13/2010 | US7695936 Knobs and holes heteromeric polypeptides |
| 04/13/2010 | CA2449747C Use of fkbp chaperones as expression tool |
| 04/13/2010 | CA2348773C Functional antagonists of hedgehog activity |
| 04/13/2010 | CA2318482C Il-18 receptors |
| 04/13/2010 | CA2219948C Single chain gonadotropins, dna encoding them and method of producing |
| 04/13/2010 | CA2089229C Cd40cr receptor and ligands therefor |
| 04/08/2010 | WO2010039224A2 Respiratory syncytial virus (rsv) sequences for protein expression and vaccines |
| 04/08/2010 | WO2010037284A1 Polypeptides for treating or preventing cancers, the derivative products and uses thereof |
| 04/08/2010 | WO2009137721A3 Lysosomal targeting peptides and uses thereof |
| 04/08/2010 | US20100087632 VEGF-Binding Fusion Proteins and Therapeutic Uses Thereof |
| 04/07/2010 | EP2172551A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/07/2010 | EP2172488A1 Material with immunogenicity |
| 04/07/2010 | EP2172484A2 Serum albumin binding proteins |
| 04/07/2010 | EP2172476A2 Compositions and methods for WT1 specific immunotherapy |
| 04/07/2010 | EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 04/07/2010 | EP2170380A1 Capsid proteins and uses therefore |
| 04/07/2010 | EP1240331B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/07/2010 | CN1769298B Fusion protein with antitumour action and its coding gene and uses |
| 04/07/2010 | CN101691406A New fusion protein SSI, application and special gene thereof |
| 04/07/2010 | CN101691405A Fusion antigen uses as vaccine |
| 04/06/2010 | US7691973 GFRα3 polypeptides |
| 04/06/2010 | US7691969 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 04/06/2010 | US7691804 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth |
| 04/06/2010 | US7691606 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
| 04/06/2010 | US7691414 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 04/06/2010 | US7691373 Antibody that binds to mammalian Dendritic Cell Membrane Protein (DCMP) genes; immunostimulants |
| 04/06/2010 | US7691366 Chimeric CMP-Ang1 molecule |
| 04/06/2010 | CA2445035C Mutants of green fluorescent protein |
| 04/06/2010 | CA2406807C Methods and compositions for the prevention and treatment of anemia |
| 04/06/2010 | CA2378925C Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 04/06/2010 | CA2331274C Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 04/03/2010 | CA2640416A1 Bifunctional fusion molecules for the delivery of antigens to professional antigen-presenting cells |
| 04/01/2010 | WO2010037135A2 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them |
| 04/01/2010 | WO2010035756A1 Immunoglobulin-binding protein |
| 04/01/2010 | WO2009140666A3 METHODS AND REAGENTS FOR DETECTING CpG METHYLATION WITH A METHYL CpG BINDING PROTEIN (MBP) |
| 04/01/2010 | US20100083403 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 04/01/2010 | US20100080820 Preparation of a Therapeutic Composition |
| 04/01/2010 | US20100080793 DcR3 polypeptide, A TNFR homolog |
| 03/31/2010 | EP2168987A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 03/31/2010 | EP2168981A2 A Fibrin/Fibrinogen-binding conjugate |